Larvol Delta - PROCESSA-PHARMACEUTICALS-ANNOUNCES-THE-LICENSING-OF-AN-ANTIFIBROTIC-ANTIINFLAMMATORY-DRUG-FOR-THE-TREATMENT-OF-MULTIPLE-UNMET-MEDICAL-NEED-CONDITIONS

Tempostatin (halofuginone) - Akashi Therap

http://www.globenewswire.com/news-release/2019/09/03/1910115/0/en/PROCESSA-PHARMACEUTICALS-ANNOUNCES-THE-LICENSING-OF-AN-ANTI-FIBROTIC-ANTI-INFLAMMATORY-DRUG-FOR-THE-TREATMENT-OF-MULTIPLE-UNMET-MEDICAL-NEED-CONDITIONS.html

Sep 3, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next